Ep. 169 - Conor Gallagher on Building a Biotech Pipeline for Aesthetics and Therapeutics episode artwork

EPISODE · Aug 27, 2024 · 38 MIN

Ep. 169 - Conor Gallagher on Building a Biotech Pipeline for Aesthetics and Therapeutics

from Technology of Beauty · host The Technology of Beauty

As the Chief Scientific Officer at Revance, Conor Gallagher spearheads R&D, process and analytical development under the umbrella of scientific innovation while also leading a team working on Revance's biosimilar program. With the stated goal of setting a "new standard in healthcare by elevating patient and physician experiences," Revance boasts an impressive lineup of aesthetic and therapeutic offerings. Notable among these are the RHA Collection of dermal fillers, designed to adapt to dynamic facial movements for natural-looking results, and Daxxify, a long-lasting/fast-acting neurotoxin for smoothing frown lines that is powered by a novel peptide. What's more, Daxxify was recently approved for FDA approved for the treatment of cervical dystonia in adults.And the future is looking even brighter with the recent announcement that Revance has entered into a merger agreement with Crown Laboratories to bring together their complementary product lines to create a leading, innovative, high-growth aesthetics and skincare company.So tune in for a sneak peek at what's next in the biotech pipeline at Revance — and soon to be Crown Laboratories — on the latest episode of The Technology of Beauty.» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/» Instagram | https://www.instagram.com/thetechnologyofbeauty/» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

Episode metadata supplied by the publisher feed · Published Aug 27, 2024

Embed this episode

As the Chief Scientific Officer at Revance, Conor Gallagher spearheads R&D, process and analytical development under the umbrella of scientific innovation while also leading a team working on Revance's biosimilar program. With the stated goal of setting a "new standard in healthcare by elevating patient and physician experiences," Revance boasts an impressive lineup of aesthetic and therapeutic offerings. Notable among these are the RHA Collection of dermal fillers, designed to ada...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Ep. 169 - Conor Gallagher on Building a Biotech Pipeline for Aesthetics and Therapeutics

0:00 38:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Technology of Beauty?

This episode is 38 minutes long.

When was this Technology of Beauty episode published?

This episode was published on August 27, 2024.

Can I download this Technology of Beauty episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!